header

Detection and quantification of antibodies to biopharmaceuticals (Record no. 223811)

MARC details
000 -LEADER
fixed length control field 03780nam a2200373 a 4500
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.07/98
245 00 - TITLE STATEMENT
Title Detection and quantification of antibodies to biopharmaceuticals
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication Hoboken, N.J. :
Name of publisher Wiley,
Year of publication c2011.
300 ## - PHYSICAL DESCRIPTION
Number of Pages xxiii, 404 p., [12] p. of plates :
Other physical details ill. (some col.)
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Principals of risk assessment and monitoring of antibody responses to biopharmaceuticals / Eugen Koren, Erik Foehr, and Charles A. O'Neill -- Immunogenicity of therapeutic proteins : a regulatory perspective / Susan Kirshner -- Guidance on immunogenicity assessment of biologically-derived therapeutic proteins : an European perspective / Meenu Wadhwa and Robin Thorpe -- Japanese regulatory perspective on immunogenicity / Takao Hayakawa and Akiko Ishii -- Enzyme immunoassays and radioimmune assays for quantification of anti-TNF biopharmaceuticals and anti-drug antibodies / Klaus Bendtzen and Morten Svenson -- Confirmatory immunogenicity assays / Eric Wakshull and Daniel Coleman -- The use of pharmacodynamics as a surrogate marker for the detection of anti-drug neutralizing antibodies / Florian Deisenhammer -- Cell-based assays for the detection of neutralizing antibodies to interferon beta (IFN-?) and tumor necrosis factor-alpha (TNF-?) inhibitors / Anthony Meager -- Detection of neutralizing antibodies (NABs) to Interferon-beta by real time RT-PCR / Francesca Gilli and Antonio Bertolotto -- Competitive ligand binding assays for the detection of neutralizing antibodies / Bonnie Wu, George R. Gunn III, and Gopi Shankar --
Formatted contents note The use of surface plasmon resonance for the detection and characterization of antibodies / Steven J. Swanson and Daniel Mytych -- Hypersensitivity reactions to biopharmaceuticals : detection and quantification of drug-specific IgE antibodies / J�rgen Dahlstr�m and Lennart Venemalm -- Standardization and validation of immunoassays and biophysical assays for the detection of anti-drug antibodies / Daniel Kramer -- Standardization and validation of cell-based assays for the detection of neutralizing anti-drug antibodies / Deborah Finco-Kent and Amy Grenham -- Standardization of neutralizing antibody unitge by bioassay design : constant antigen and constant antibody methodology / Sidney E. Grossberg, Yoshimi Kawade, and Leslie D. Grossberg -- Cut-points and performance characteristics for anti-drug antibody assays / Viswanath Devanarayan and Michael G. Tovey -- Dilutional linearity for neutralizing antibody assays / David Lansky and Carrie Wager -- Detection of neutralizing antibodies to biopharmaceuticals in the presence of high levels of circulating drug / Arno Kromminga and Michael G. Tovey.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical Term Immunoglobulins
Topical Term Immunoassay.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tovey, Michael G.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://site.ebrary.com/lib/rucke/Doc?id=10484657

No items available.

© 2026 Rongo University
Contact us: librarian | system librarian | Rongo university